Can a Selective PPARγ Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone? - DePaoli, Alex M.; Higgins, Linda S.; Henry, Robert R.; Mantzoros, Christos; Dunn, Fredrick L. (Diabetes care, 2014)
Keywords: Adult; Aged; Blood Glucose - drug effects; Diabetes Mellitus, Type 2 - drug therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glycated Hemoglobin A - metabolism; Humans; Hypoglycemic Agents - adverse effects; Hypoglycemic Agents - pharmacology; Hypoglycemic Agents - therapeutic use; Male; Metformin - administration & dosage; Metformin - therapeutic use; Middle Aged; PPAR gamma - agonists; Prospective Studies; Quinolines - adverse effects; Quinolines - pharmacology; Quinolines - therapeutic use; Sulfonamides - adverse effects; Sulfonamides - pharmacology; Sulfonamides - therapeutic use; Sulfonylurea Compounds - therapeutic use; Thiazolidinediones - adverse effects; Thiazolidinediones - therapeutic use; Treatment Outcome; Weight Gain - drug effects